|51.09||+3.01 / +6.26%|
Data as of 4:00pm ET
|50.24||-0.85 / -1.66%|
The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 92.00, with a high estimate of 98.00 and a low estimate of 44.00. The median estimate represents a +80.07% increase from the last price of 51.09.
The current consensus among 5 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.